Curex
Telemedicine & Virtual Care · Cell & Gene Therapy
$46.4Mtotal raised · 4 rounds on record
$5Mlatest round · Venture round · Jun 2021 · 5 yr ago
1backers · Plug and Play
10+team · employees, estimated range
Overview
The #1 online at-home allergy clinic that offers the most affordable and convenient allergy treatment including sublingual allergy drops & immunotherapy.
Funding and backers
Total raised
$46.4M
4 rounds on record
Latest round
$5M
Venture round · Jun 2021 · 5 yr ago
Team
11-50
employees, estimated range
Backers
1
Plug and Play
The money's age
Long since its last round
64 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 30, 2024
Launched Curex Introduces a Safer, At-Home Alternative to Food Oral Immunotherapy · YahooFinance
Jun 15, 2021
Raised a round Venture round $5M · SEC Form D
Nov 2020
Website went live first capture in the Wayback Machine
Dec 2, 2019
Board appointment Brian Thebault, Director · SEC Form D
Nov 22, 2019
Raised a round Venture round $21.4M · SEC Form D
Nov 28, 2017
Board appointment David Bizer, Director · SEC Form D
Nov 9, 2017
Raised a round Venture round $10M · SEC Form D
Aug 9, 2016
Raised a round Venture round $10M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2021 | $5M | — | SEC Form D |
| Venture round | Nov 2019 | $21.4M | — | SEC Form D |
| Venture round | Nov 2017 | $10M | — | SEC Form D |
| Venture round | Aug 2016 | $10M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Curex Group Holdings, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert FeeneyExecutive OfficerSEC Form D
Saul SarrettExecutive OfficerSEC Form D
Zoran MavrinacExecutive OfficerSEC Form D
James SingletonExecutive Officer, DirectorSEC Form D
Michael WilliamsExecutive Officer, DirectorSEC Form D
Franz SchmidpeterExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
At AllergenIQ, our allergist offers at-home allergy testing and tailored treatment plans for kids and parents. Book your virtual…
FAIT connects clinics and families through the allergy treatment journey with AI powered insights, proactive monitoring, and seamless…
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges…
People
Robert Feeney
Executive Officer
Saul Sarrett
Executive Officer
Zoran Mavrinac
Executive Officer
James Singleton
Executive Officer, Director
Michael Williams
Executive Officer, Director
Franz Schmidpeter
Executive Officer
Charles Flynn
Director
Steven Gruber
Director
J. Brian Thebault
Director
William Cruger
Director
James Alexander
Director
David Bizer
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Plug and PlayVia a fund
2741 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Curex Releases Largest Real-World Study Telemedicine Allergy Drops: High Adherence, Symptom Improvement
Curex Releases Largest Real-World Study Telemedicine Allergy Drops: High Adherence, Symptom Improvement
Read more
Report
Frontiers Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform: a retrospective longitudinal cohort study
BackgroundAllergen immunotherapy (AIT) is a disease-modifying treatment for IgE-mediated respiratory allergy, but real-world use is limited by access and adh...
Read more
Report
Curex Is Making Allergy Care As Easy As Your Morning Routine
Curex offers personalized allergy drops, making long-term relief easy and hassle-free-no more shots or waiting rooms.
Read more
Report
Curex Is Making Food Allergy Care Easier Than Ever, Backed by Science
Fewer severe reactions and the ability to enjoy meals without fear are two key benefits of using SLIT drops for food allergies.
Read more
Report
Curex Introduces a Safer, At-Home Alternative to Food Oral Immunotherapy
Miami, FL, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Curex, the leader in telemedicine allergy immunotherapy treatments, announces the launch of its innovative at-home Sublingual Immunotherapy (SLIT) program to treat food allergies. This new offering aims to help
Read more
Report
Curex Revolutionizing Allergy Immunotherapy with Telehealth and Home-Delivered Allergy Drops
New York,NY, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Allergy sufferers looking to treat their allergies without the pain and inconvenience of weekly visits to their doctor now have an ally in an at-home allergy offering developed by Curex. Online allergy clinic
Read more
Report
Why 75% of allergy sufferers quit allergy shots within a year, and how Curex provides a better solution
Curex is leading the charge, offering an easier and more attractive alternative: sublingual immunotherapy or allergy drops.
Read more
Report
How Curex's at-home allergy testing and immunotherapy treatment could help you manage environmental allergies
If you live with mild to moderate environmental allergies, you may be able to treat them with immunotherapy - and you can order this treatment online with Curex.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
New York
United States
HQ
1732 1st Ave #20213, New York, NY, 10128, US
Miami
United States
Regional office